{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autoimmune-lymphoproliferative-syndrome-type-2b","columns":[{"gene":"","key":"population-ff4edd6092873046b510","label":"Autoimmune lymphoproliferative syndrome, type IIB","mondoId":"MONDO:0011804","onsetQualifier":null,"originColumnKey":"MONDO:0011804/OMIM:607271","originalViews":[{"key":"MONDO:0011804/OMIM:607271","label":"Autoimmune lymphoproliferative syndrome, type IIB","scopeLabel":"OMIM:607271","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["06a722b1414b5db0fca407dd4f5386963abdbbf26b3077fbe499b7e2da7a0247","073d31ec3fdddd10ded43ee8761f0c2e24337d864dd6188276c944e042980115","0ed43c0db050c33c9406e691489c2e306ae97c6e8c123e8b7c0eff0cef88bfbb","164de7f65e9d31da6c02f7dab4258181c19f12dca46962655f2477cc34fa7c9c","36dde5d7a65d9e5990ca740b8e409717498c7c2aa0724ad82c4bc92899e80300","4a943cf164ec987075c3fc3722341de27c6a363a0b7fd78ae44f87f94750eef6","4db0f9761722e91e5ca5c02d088600238fd7ac85d981068ba99b2441995f3917","53d3112579b96d737ee38e32830791c1f154d38b476fbe3441f77df60486c344","6958904f1fe1868cd7066e9f687640c1fba6d3d181c6b78af58bc2cfb7ac98ee","781fdfb8380a99b58cb392af3ae6f48c5584fb7a332ec438a6732c2604d2a551","7d19d53bf63e53121709b46fd513b55146032cfe79769e79e1392e131f883312","9718c2b22214bde46cc654de6e90b49b1baec95daf6f09f5d39e557db1f11edc","9f826f5cc6869f0cc8fde3408c7bbbc5a050e3b25ede209145ad427d4f916a77","a27559ed1b4072407ccb36ac85468cbc097f8d1061499f20c20769b22065cca7","e2377228f3118d67ba5103f5c3641f660e42fc137357c59eef31ff8b58e7e6ca","ed6b2d866eab1de91563dc01cf34191800aec71fb1cf0a04ae758aa7f89c4281","fb17a41d886d677c543245f705ca1fcec424ed12d199c1bb5bd1ccb8a3f81065","ffb224b530619500e2070c1f7a606e6a386a6d542a481786b18551d8c3b3cc05"],"recordQualifiers":{},"scopeLabel":"OMIM:607271","sourceIds":["OMIM:607271"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ff4edd6092873046b510"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002099","HP:0002028","HP:0410300","HP:0002720","HP:0004315","HP:0002850","HP:0005419"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":18,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":18,"sourceGroups":{"published":18}},"features":[{"hpoId":"HP:0002099","label":"Asthma","primary":true},{"hpoId":"HP:0002028","label":"Chronic diarrhea","primary":true},{"hpoId":"HP:0410300","label":"Complete or near-complete absence of specific antibody response to unconjugated pneumococcus polysaccharide","primary":true},{"hpoId":"HP:0002720","label":"Decreased circulating IgA concentration","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":true},{"hpoId":"HP:0002850","label":"Decreased circulating IgM concentration","primary":true},{"hpoId":"HP:0005419","label":"Decreased T cell activation","primary":true},{"hpoId":"HP:0005384","label":"Defective B cell activation","primary":false},{"hpoId":"HP:0000964","label":"Eczematoid dermatitis","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0033222","label":"Inverted CD4:CD8 ratio","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0002090","label":"Pneumonia","primary":false},{"hpoId":"HP:0005353","label":"Recurrent herpes","primary":false},{"hpoId":"HP:0005425","label":"Recurrent sinopulmonary infections","primary":false},{"hpoId":"HP:0033278","label":"Reduced CD95-induced lymphocyte apoptosis","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"A rare genetic disorder characterized by lymphadenopathy and/or splenomegaly and recurrent infections due to herpes viruses.","mondoId":"MONDO:0011804","node":{"canonicalSlug":"autoimmune-lymphoproliferative-syndrome-type-2b","comparisons":[{"documentSha256":"b24598e5e8ef9fb461e0589c499ee1d42343699ab60d2a8e72eb2bdc05b0f269","key":"legacy-autoimmune-lymphoproliferative","kind":"legacy","label":"autoimmune lymphoproliferative syndrome","memberIds":["MONDO:0011158","MONDO:0011383","MONDO:0011804","MONDO:0013767","MONDO:0014493","MONDO:0017979","MONDO:8000024"],"mondoId":"MONDO:0017979","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autoimmune-lymphoproliferative.b24598e5e8ef9fb461e0589c499ee1d42343699ab60d2a8e72eb2bdc05b0f269.json"},{"documentSha256":"2a8dea17ad3684543a532636b1570fe11ac8e4f110741a3c752dca9ca9c3d80a","key":"expanded-autoimmune-lymphoproliferative","kind":"expanded","label":"autoimmune lymphoproliferative syndrome","memberIds":["MONDO:0011158","MONDO:0011383","MONDO:0011804","MONDO:0013767","MONDO:0014493","MONDO:0017979","MONDO:0018702","MONDO:1060194","MONDO:8000023","MONDO:8000024"],"mondoId":"MONDO:0017979","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-2a8dea17ad3684543a53.2a8dea17ad3684543a532636b1570fe11ac8e4f110741a3c752dca9ca9c3d80a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autoimmune lymphoproliferative syndrome type 2B","originalSourceId":"ORPHA:275517","paragraphs":["A rare genetic disorder characterized by lymphadenopathy and/or splenomegaly and recurrent infections due to herpes viruses."],"rawAttribution":"MONDO:0011804","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:47Z","upstream":"MONDO:0011804","url":"https://rarediseases.info.nih.gov/diseases/9796"},"ownColumnKeys":["population-ff4edd6092873046b510"],"publication":"published","relationships":[{"kind":"parent","label":"autoimmune lymphoproliferative syndrome","mondoId":"MONDO:0017979","slug":"autoimmune-lymphoproliferative"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"06a722b1414b5db0fca407dd4f5386963abdbbf26b3077fbe499b7e2da7a0247","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0033222","is_excluded":false,"label":"Inverted CD4:CD8 ratio","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"073d31ec3fdddd10ded43ee8761f0c2e24337d864dd6188276c944e042980115","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0005419","is_excluded":false,"label":"Decreased T cell activation","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0ed43c0db050c33c9406e691489c2e306ae97c6e8c123e8b7c0eff0cef88bfbb","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000964","is_excluded":false,"label":"Eczematoid dermatitis","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"164de7f65e9d31da6c02f7dab4258181c19f12dca46962655f2477cc34fa7c9c","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002090","is_excluded":false,"label":"Pneumonia","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"36dde5d7a65d9e5990ca740b8e409717498c7c2aa0724ad82c4bc92899e80300","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4a943cf164ec987075c3fc3722341de27c6a363a0b7fd78ae44f87f94750eef6","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0410300","is_excluded":false,"label":"Complete or near-complete absence of specific antibody response to unconjugated pneumococcus polysaccharide","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4db0f9761722e91e5ca5c02d088600238fd7ac85d981068ba99b2441995f3917","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"53d3112579b96d737ee38e32830791c1f154d38b476fbe3441f77df60486c344","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0033278","is_excluded":false,"label":"Reduced CD95-induced lymphocyte apoptosis","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6958904f1fe1868cd7066e9f687640c1fba6d3d181c6b78af58bc2cfb7ac98ee","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002028","is_excluded":false,"label":"Chronic diarrhea","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"781fdfb8380a99b58cb392af3ae6f48c5584fb7a332ec438a6732c2604d2a551","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7d19d53bf63e53121709b46fd513b55146032cfe79769e79e1392e131f883312","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002099","is_excluded":false,"label":"Asthma","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9718c2b22214bde46cc654de6e90b49b1baec95daf6f09f5d39e557db1f11edc","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002850","is_excluded":false,"label":"Decreased circulating IgM concentration","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9f826f5cc6869f0cc8fde3408c7bbbc5a050e3b25ede209145ad427d4f916a77","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0005384","is_excluded":false,"label":"Defective B cell activation","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a27559ed1b4072407ccb36ac85468cbc097f8d1061499f20c20769b22065cca7","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0005353","is_excluded":false,"label":"Recurrent herpes","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e2377228f3118d67ba5103f5c3641f660e42fc137357c59eef31ff8b58e7e6ca","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ed6b2d866eab1de91563dc01cf34191800aec71fb1cf0a04ae758aa7f89c4281","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0005425","is_excluded":false,"label":"Recurrent sinopulmonary infections","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fb17a41d886d677c543245f705ca1fcec424ed12d199c1bb5bd1ccb8a3f81065","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ffb224b530619500e2070c1f7a606e6a386a6d542a481786b18551d8c3b3cc05","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:607271","disease_name":"Autoimmune lymphoproliferative syndrome, type IIB","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002720","is_excluded":false,"label":"Decreased circulating IgA concentration","onset_id":null,"reference":"PMID:12353035","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9796\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011804\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0011804</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic disorder characterized by lymphadenopathy and/or splenomegaly and recurrent infections due to herpes viruses.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9796\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"autoimmune-lymphoproliferative-syndrome-type-2b","sourceDocuments":[{"name":"GARD: Autoimmune lymphoproliferative syndrome type 2B","reviewed":null,"source_release":"2026-10-25T03:40:47Z","url":"https://rarediseases.info.nih.gov/diseases/9796"},{"name":"MONDO: autoimmune lymphoproliferative syndrome type 2B","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011804"}],"sourceNote":"","synonyms":["ALPS2B","autoimmune lymphoproliferative syndrome caused by mutation in CASP8","autoimmune lymphoproliferative syndrome, type IIB","CASP8 autoimmune lymphoproliferative syndrome","caspase 8 deficiency","caspase 8 deficiency syndrome","caspase-8 deficiency","CEDS"],"takeawayHtml":"","title":"autoimmune lymphoproliferative syndrome type 2B"},"schemaVersion":1}
